logo
AI Icon𝛼SK or Search
ENTITY
Dechra Pharmaceuticals

Dechra Pharmaceuticals (DPH LN)

44
Analysis
Health Care • United Kingdom
Dechra Pharmaceuticals is a global specialist in the development, manufacture, and marketing of high-quality veterinary pharmaceuticals and related products, focusing on companion animals, equine, and food-producing animals. Key products include treatments for endocrinology, dermatology, and pain management, such as Vetoryl for Cushing's disease in dogs and Felimazole for hyperthyroidism in cats. The company was founded in 1997 and moved its global headquarters to Boston, Massachusetts, in June 2026.
more
Exchange Announcement • 17 Jan 2024 00:54

Holding(s) in Company

Exchange Announcement • 16 Jan 2024 22:43

Holding(s) in Company

Exchange Announcement • 16 Jan 2024 20:04

Holding(s) in Company

Exchange Announcement • 16 Jan 2024 17:00

Holding(s) in Company

Exchange Announcement • 16 Jan 2024 00:51

Director/PDMR Shareholding

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x